⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16714237 | 0.87 | — | — | |
| SCHEMBL7022586 | 0.81 | — | — | |
| SCHEMBL18422096 | 0.79 | — | — | |
| SCHEMBL6670754 | 0.78 | — | — | |
| SCHEMBL24092185 | 0.76 | — | — | |
| SCHEMBL15210986 | 0.76 | — | — | |
| SCHEMBL261953 | 0.75 | — | — | |
| SCHEMBL30440873 | 0.75 | SIGMAR1 (0.38) | — | |
| SCHEMBL4104111 | 0.74 | — | — | |
| SCHEMBL1980100 | 0.74 | ADH1B (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350093-B2 | Methylated curcumin-resveratrol hybrid molecules for treating cancer | CODMAN & SHURTLEFF, INC. (US) | 2013-01-08 | — | — | US | disclosed |
| US-20110130392-A1 | Method of Administering a Methylene Blue - Curcumin Analog for the Treatment of Alzheimer's Disease | DEPUY SPINE, LLC | 2011-06-02 | — | — | US | disclosed |
| US-7906643-B2 | Methylene blue-curcumin analog for the treatment of Alzheimer's Disease | CODMAN & SHURTLEFF, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| US-20100292512-A1 | Methylated Curcumin-Resveratrol Hybrid Molecules for Treating Cancer | DEPUY SPINE, LLC | 2010-11-18 | — | — | US | disclosed |
| US-20100190978-A1 | METHYLENE BLUE - CURCUMIN ANALOG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | CODMAN & SHURTLEFF, INC. | 2010-07-29 | — | — | US | disclosed |
| US-7745670-B2 | Curcumin-Resveratrol hybrid molecule | CODMAN & SHURTLEFF, INC. (US) | 2010-06-29 | — | — | US | disclosed |
| US-7723515-B1 | Methylene blue—curcumin analog for the treatment of alzheimer's disease | CODMAN & SHURTLEFF, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-20090326275-A1 | USE OF NITROGEN-CONTAINING CURCUMIN ANALOGS FOR THE TREATMENT OF ALZHEIMERS DISEASE | DEPUY SPINE, LLC | 2009-12-31 | — | — | US | disclosed |